Citation 1:
    Title: Johnson & Johnson reports Q2 2024 results | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2024/Johnson--Johnson-reports-Q2-2024-results/default.aspx#:~:text=%2A%202024%20Second,due
    Location: chars 180–343

Citation 2:
    Title: Johnson & Johnson Reports Q1 2025 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2025/Johnson--Johnson-Reports-Q1-2025-Results/default.aspx#:~:text=DARZALEX%20%20,2.2%20%20%7C
    Location: chars 606–773

Citation 3:
    Title: Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2025/Johnson--Johnson-Closes-Landmark-Intra-Cellular-Therapies-Inc--Acquisition-to-Solidify-Neuroscience-Leadership/default.aspx#:~:text=NEW%20BRUNSWICK%2C%20N.J.,Johnson%20%26%20Johnson%20Innovative%20Medicine
    Location: chars 944–1227

Citation 4:
    Title: Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2025/Johnson--Johnson-Closes-Landmark-Intra-Cellular-Therapies-Inc--Acquisition-to-Solidify-Neuroscience-Leadership/default.aspx#:~:text=04%2F02%2F2025
    Location: chars 1228–1452

Citation 5:
    Title: Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results | Intra-Cellular Therapies Inc.
    URL: https://ir.intracellulartherapies.com/news-releases/news-release-details/intra-cellular-therapies-reports-fourth-quarter-and-full-year-10#:~:text=Fourth%20quarter%202024%20CAPLYTA%20net,the%20same%20period%20in%202023
    Location: chars 1529–1781

Citation 6:
    Title: Johnson & Johnson Completes Acquisition of Shockwave Medical | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2024/Johnson--Johnson-Completes-Acquisition-of-Shockwave-Medical/default.aspx#:~:text=NEW%20BRUNSWICK%2C%20N.J.,a%20business%20unit%20within%20Johnson
    Location: chars 1872–2095

Citation 7:
    Title: Johnson & Johnson Reports Q1 2025 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2025/Johnson--Johnson-Reports-Q1-2025-Results/default.aspx#:~:text=STELARA%20%20,1.4%20%20%7C
    Location: chars 2386–2552

Citation 8:
    Title: Johnson & Johnson reports Q2 2024 results | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2024/Johnson--Johnson-reports-Q2-2024-results/default.aspx
    Location: chars 3148–3279

Citation 9:
    Title: Johnson & Johnson reports Q2 2024 results | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2024/Johnson--Johnson-reports-Q2-2024-results/default.aspx#:~:text=Net%20earnings%20from%20Continuing%20Operations,
    Location: chars 3280–3468

Citation 10:
    Title: Johnson & Johnson reports Q2 2024 results | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2024/Johnson--Johnson-reports-Q2-2024-results/default.aspx#:~:text=Reported%20Sales%20%20,5.9
    Location: chars 3709–3875

Citation 11:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=Free%20Cash%20Flow%20%28YTD%29,%2488%2C821
    Location: chars 4236–4410

Citation 12:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=Reported%20Sales%20,Net%20Earnings
    Location: chars 4411–4577

Citation 13:
    Title: Johnson & Johnson reports Q2 2024 results | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2024/Johnson--Johnson-reports-Q2-2024-results/default.aspx#:~:text=%2A%202024%20Second,due
    Location: chars 4796–4959

Citation 14:
    Title: Johnson & Johnson reports Q2 2024 results | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2024/Johnson--Johnson-reports-Q2-2024-results/default.aspx#:~:text=%2A%202024%20Second,due
    Location: chars 5558–5721

Citation 15:
    Title: Johnson & Johnson Reports Q1 2025 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2025/Johnson--Johnson-Reports-Q1-2025-Results/default.aspx#:~:text=DARZALEX%20%20,2.2%20%20%7C
    Location: chars 5722–5889

Citation 16:
    Title: Johnson & Johnson Reports Q1 2025 Results | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2025/Johnson--Johnson-Reports-Q1-2025-Results/default.aspx#:~:text=STELARA%20%20,1.4%20%20%7C
    Location: chars 5890–6056

Citation 17:
    Title: Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership | Johnson & Johnson
    URL: https://www.investor.jnj.com/news/news-details/2025/Johnson--Johnson-Closes-Landmark-Intra-Cellular-Therapies-Inc--Acquisition-to-Solidify-Neuroscience-Leadership/default.aspx#:~:text=NEW%20BRUNSWICK%2C%20N.J.,Johnson%20%26%20Johnson%20Innovative%20Medicine
    Location: chars 6057–6340

Citation 18:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=Free%20Cash%20Flow%20%28YTD%29,%2488%2C821
    Location: chars 6383–6557

Citation 19:
    Title: Johnson & Johnson reports Q4 2024 and Full-Year 2024 results
    URL: https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q4-2024-and-full-year-2024-results#:~:text=Reported%20Sales%20,Net%20Earnings
    Location: chars 6558–6724

